Puration, Inc. (USOTC: PURA) currently declared the company is in the beginning forecasting $1 million in income for 2022. Administration thinks the forecast is conservative and anticipates possibly revisiting the earnings forecast in excess of at the time upcoming 12 months. Jazz Prescribed drugs entered the cannabis marketplace in May https://www.medknow.com/crt.asp?prn=20&aid=IJCCM_2015_19_4_220_154556&rt=P&u=https://www.investinweed.com/